1. Danser A.H., Schalekamp M.A., Bax W.A. et al. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995; 92: 1387-8.
2. Combien E., Albenc-Gelas F., Herthet B. et al. Familial resemblance of plasma angiotensin-converting enzyme level. The Nancy study. Am J Hum Genet 1998, 774-80.
3. Atvarez R., Reguero J.R., Batalla A. et al. Angiotenzin-converting enzyme and angiotensin II receptor I polymorphism association with early coronary disease. Cardiovasc Res 1998: 40; 375-9.
4. Fatini C., Abbate R., Pepe G. el at Searching for a a better assessment of the individual coronary risk profile: the role of angiotensin-converting enzyme, angiotensin II type I receptor and angiotensinogen gene polymorphisms. Eur Heart J 2000, 21, 633-8.
5. Andrsson B., Sylven C. The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality m idiopathic heart failure. J Am Coll Cardiol 1996. 28. 162-7.
6. Ishigava U., Uramoto T., Tannura K. et al. Angiotensin I converting enzyme (ACE) gene polymorphism and essential hypertension in Japan. Ethnic difference of ACE genotype. Am J Hypertens 1995, 8, 95-7.
7. Nakabara K., Matsushita S., Matsuoka H. Insertion-deletion polymorphism in the angiotensin-converting enzyme gene affects cardiac weight, Circulation 2000. 101-148-51.
8. Leebin M., Qutcones M.A., Omran A. et al. Angiotensin-converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 1995: 92: 1808-12.
9. Muider H.J., xan Geet P.P., Schalty M.J. et al. PREFACE trial DD ACE gene polymorphism is associated with increased coronary artery endothelial dysfunction the PREFACE trial. Heart 2003. 89, 557-8.
10. Bloem L.J., Manatiagna A.K., Takeda R. The Serum angiotensinogen on centration and the angiotensinogen in white and black children. J Clean Invest 1995, 95, 948-53.
11. Danser A.H., Derky F.H., Hense H.W. et al. Angiotensinogen (M2353) and angiotensine converting enzyme (ID) polymorphisms in association with plasma renin and propenin levels. J Hypertens 1998: 16: 1879-83.
12. Bonnardeanx A., Davies F., Jeunemaitre N. Angiotensin II type I receptor gene polymorphism in human essential hypertension. Hypertension 1994, 24, 63-9.
13. Staessen J.A., Ginocchio G., Wang J.G. et al. Genetic variability in the renin-angiotensin system, prevalence of alleles and genotypes. Cardiovasc Risk 1997, 4, 401-22.
14. Cambien V., Fowier O., Ucerf et al. Deletion polymorphism in the gene for angiotensine-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992: 359: 641-4.
15. Hert L., Kee V., Poeven O. et al. Deletion polymorphism in angiotensine-converting ensyme gene associated with parental history of myocardial infarction. Lancet 1993: 341: 1991-2.
16. Agerbolm Larsen B., Nordestgaard B.G., Tyhi rg rg-Hansen A. ACE genе polymorphism in cardiovascular disease. Meta analyses of small and large studies in whites. Arteroscler Thromb Vasc Biol 2000: 20: 484-92.
17. Samami N.J., Thompson J.R., O'Toote L. et al. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996; 94; 708-12.
18. Butler R., Morris A.D., Stretbers A.D. Angiotensin-converting enzyme gene polymorphism and cardiovascular disease. Clin Sci 1997: 93: 391-400.
19. Кириченко Н.Ю. Роль гемодинамических конституционных и генетических факторов в формировании хронической недостаточности кровообращения. Дис. … канд. мед. наук. СПб., 2001
20. Сandy G.P., Skudicky D., Mueller U.K. et al. Association on left ventricular systolic performance and cavity size with angiotensin-converting enzyme genotype in idiopathic dilated cardiomyopathy. Am J Cardiol 1999: 83: 740-4.
21. Rodriguez-Perez J.G., Rodriguez-Esparragon F., Hernandez-Perera O. Association of angiotensinogen M235T and A (-6) G gene polymorphism with coronary heart disease with independence of essential hypertension: the PROCAGENE study. Prospective Cardiac Gene. J Am Coll Cardiol 2001: 37: 1536-42.
22. Katsuya T., Koike G., Yee T.W. et al. Association of angiotensinogen geneT235 variant with increased risk of coronary heart disease. Lancet 1905; 345: 1600-3.
23. Cong N.D., Hamaguchi K., Saikava T. et al. A polymorphism of angiotensinogen gene codon174 and coronary artery disease in Japanese subjects. Am J Med Sci 1998: 316: 339-44.
24. Niang K., Zheng T., Sun D., Li J. The Relationship angiotensin II type I receptor gene and coronary heart disease hypertension and diabetes mellitus in Chinese. Zhonghna Yi., Xue Yi., Chuan Za Zhi 1998: 15: 9-12.
25. Zedda N., Onni S., Angius A. et al. Does a genetic predisposition for infarction expansion exist? Evaluation of genetic polymorphism of the renin-angiotensin system. H. Cardiologia 1997: 42: 281-5.
26. Hamon M., Amant C., Beuters C. et al. Dual determination of angiotensin converting enzyme and angiotensin II type I receptor genotypes as predictors of restenosis after coronary angioplasty. Am J Cardiol 1998: 81: 79-81.
27. Hamon M., Fradin S., Denzet A. et al. Prospective evaluation of the effect of an angiotensin I converting ensyme gene polymorphism on the long term risk of major adverse cardiac events after percutaneous coronary intervention. Heart 2003: 89: 321-5.
28. Poirier O., Georges J.L., Ricard S. et al. New polymorphism of the angiotensine II type I receptor gene and blood pressure. The ECTIM study. Elude Cas-Temoin de Ingarctus du Myocarde. J Hypertens 1998: 16: 1443-7.
